KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,329 | -29.0% | 5,434 | -33.7% | 0.00% | – |
| Q2 2023 | $73,728 | +3.1% | 8,192 | -10.0% | 0.00% | – |
| Q1 2023 | $71,526 | +8.3% | 9,100 | -6.9% | 0.00% | – |
| Q4 2022 | $66,052 | -52.8% | 9,771 | +1.1% | 0.00% | – |
| Q3 2022 | $140,000 | +35.9% | 9,661 | -7.7% | 0.00% | – |
| Q2 2022 | $103,000 | -27.5% | 10,467 | +8.7% | 0.00% | – |
| Q1 2022 | $142,000 | -12.9% | 9,631 | -21.7% | 0.00% | – |
| Q4 2021 | $163,000 | -12.8% | 12,298 | +14.6% | 0.00% | – |
| Q3 2021 | $187,000 | -71.5% | 10,733 | -60.8% | 0.00% | -100.0% |
| Q2 2021 | $657,000 | -11.0% | 27,415 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $738,000 | +76.1% | 28,739 | +30.2% | 0.00% | 0.0% |
| Q4 2020 | $419,000 | +63.0% | 22,080 | +8.2% | 0.00% | – |
| Q3 2020 | $257,000 | +8.4% | 20,406 | +4.4% | 0.00% | – |
| Q2 2020 | $237,000 | +58.0% | 19,546 | 0.0% | 0.00% | – |
| Q1 2020 | $150,000 | -56.4% | 19,546 | +1.2% | 0.00% | -100.0% |
| Q4 2019 | $344,000 | +65.4% | 19,321 | +7.5% | 0.00% | – |
| Q3 2019 | $208,000 | -47.7% | 17,971 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $398,000 | – | 17,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |